Medical Imaging Services for Oncology Clinical Trials

PPD offers an integrated and seamless approach to clinical development and medical imaging for oncology research. This unique offering allows clients to benefit from efficiencies; make fast, confident go/no go decisions in early phase research; or determine study endpoints quickly in later phases.

PPD’s Strategic Alliance with VirtualScopics, Inc.

The partnership provides seamless integration of technologies and processes, giving biopharmaceutical companies near real-time, consistent and reliable medical imaging information to expedite their drug development programs. The integration of services between the two companies establishes a more efficient, tailored approach across several key areas of the clinical trial process, including study start-up, screening and enrollment, protocol implementation, accurate determination and collection of endpoints related to radiographic response and progression, management of imaging data and proactive risk management.

VirtualScopics enhances PPD’s ability to provide clients with the full service, integrated solutions needed to progress drug development from early phase to regulatory approval through an innovative, patented algorithm-based approach to image processing and biomarker measurement.